Invasive Breast Carcinoma — Trials

Invasive Breast Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

296 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 103
Recruiting: 41
Ph III recruiting: 3
Growth YoY: —
Industry share: 5%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 36.8%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (43)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03077841	Hypofractionated Partial Breast Irradiation in Treating Patients With Early Stage Breast Cancer	suspended	Phase 2 / Phase 3	928	M.D. Anderson Cancer CenterOTHER	1	Sep 14, 2026	clinicaltrials
NCT02037529	Eribulin Mesylate or Paclitaxel as First- or Second-Line Therapy in Treating Patients With Recurrent Stage IIIC-IV Breast Cancer	suspended	Phase 3	201	Academic and Community Cancer Research UnitedOTHER	1	Aug 20, 2024